Skip to main content

Upstream Bio, Inc.

UPB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002022626

In the last 90 days, Upstream Bio, Inc. insiders filed 0 open-market purchases and 5 sales; 148 institutions reported holding it in 13F filings for Q2 2026, worth $350.1M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Upstream Bio, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of UPB: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders70179+10
Shares42.1M22.6K46.3M+4.23M (+10.1%)
Value$690.1M$371.3K$266.9M−$422.8M (−61.3%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Upstream Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to UPB in Q1 2025
InstitutionSharesValue% of portfolio
Altshuler Shaham Ltd3,235,293$3.52M0.09%
Parkman Healthcare Partners LLC233,563$1.43M0.17%
Schonfeld Strategic Advisors LLC177,984$1.09M0.01%
Velan Capital Investment Management LP107,000$654.8K0.67%
Millennium Management LLC61,796$378.2K0.00%
Nuveen, LLC22,586$138.2K0.00%
Two Sigma Investments, LP21,789$133.3K0.00%
Susquehanna International Group, LLP21,264$130.1K0.00%
AQR Capital Management LLC18,822$115.2K0.00%
Intech Investment Management LLC15,285$93.5K0.00%
Quantinno Capital Management LP15,225$93.2K0.00%
ADAR1 Capital Management, LLC15,000$91.8K0.02%
XTX Topco Ltd12,731$77.9K0.00%
New York State Common Retirement Fund4,700$28.8K0.00%
Police & Firemen's Retirement System of New Jersey3,350$20.5K0.00%
CWM, LLC1,596$10.0K0.00%
Versant Capital Management, Inc615$3.76K0.00%
GAMMA Investing LLC593$3.63K0.00%
Allworth Financial LP185$1.66K0.00%
Nisa Investment Advisors, LLC136$8320.00%
EverSource Wealth Advisors, LLC135$8260.00%
Signaturefd, LLC90$5510.00%
UMA Financial Services, Inc.69$4230.00%
True Wealth Design, LLC16$980.00%

Sold out (14)

Institutions that held Upstream Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of UPB in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Balyasny Asset Management LLC301,152$4.95M
Citadel Advisors LLC180,000$2.96M
Moody Aldrich Partners LLC74,773$1.23M
Soros Fund Management LLCSuperinvestorSoros Fund Management46,350$762.0K
Jane Street Group, LLC45,549$748.8K
Verition Fund Management LLC37,379$614.5K
Davidson Kempner Capital Management LP12,500$205.3K
Sandia Investment Management LP10,000$164.4K
SG Americas Securities, LLC7,590$125.0K
R Squared Ltd160$2.63K
Aster Capital Management (DIFC) Ltd134$2.20K
Caitong International Asset Management Co., Ltd44$723
Advisor Group Holdings, Inc.17$279
National Bank of Canada7$115

Not filed for Q1 2025 yet (1)

Institutions that held Upstream Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding UPB in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC22,586$371.3K